Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | -13,729 | 106,693 | 96,586 | 95,374 | 61,558 |
| Cost of Goods | N/A | 27,541 | 24,330 | 18,665 | 16,547 |
| Gross Profit | 56,807 | 79,152 | 72,256 | 76,709 | 45,011 |
| Operating Expenses | -52,899 | 40,044 | 36,065 | 42,658 | 21,720 |
| Operating Income | 39,170 | 39,649 | 36,521 | 34,716 | 23,838 |
| Interest Expense | 15,269 | 15,811 | 14,594 | 16,899 | 3,899 |
| Other Income | -167 | -116 | -429 | 35 | -114 |
| Pre-tax Income | 23,734 | 23,722 | 21,498 | 17,852 | 19,825 |
| Income Tax | 2,125 | 1,403 | 847 | 714 | -7,243 |
| Net Income Continuous | 21,609 | 22,319 | 20,651 | 17,138 | 27,068 |
| Net Income Discontinuous | -2,202 | -565 | -354 | N/A | N/A |
| Net Income | $19,407 | $21,754 | $20,297 | $17,138 | $36,563 |
| EPS Basic Total Ops | 0.90 | 1.04 | 0.98 | 0.84 | 1.88 |
| EPS Basic Continuous Ops | 1.01 | 1.07 | 1.00 | 0.84 | 1.40 |
| EPS Basic Discontinuous Ops | -0.11 | -0.03 | -0.02 | N/A | N/A |
| EPS Diluted Total Ops | 0.88 | 1.03 | 0.97 | 0.83 | 1.86 |
| EPS Diluted Continuous Ops | 0.98 | 1.06 | 0.99 | 0.83 | 1.37 |
| EPS Diluted Discontinuous Ops | -0.10 | -0.03 | -0.02 | N/A | N/A |
| EBITDA(a) | $66,674 | $68,718 | $60,398 | $65,084 | $41,474 |